Istradefylline (KW-6002)
产品编号: DCAPI1080
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Istradefylline(KW6002) is a very potent, selective and orally active adenosine A2A receptor antagonist(Ki=2.2 nM) in experimental models of Parkinson's disease.
| Cas No.: |
155270-99-8 |
| 名称: |
(E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione |
| 别名: |
|
| SMILES: |
CN1C(C(N2CC)=O)=C(N=C1/C=C/C3=CC(OC)=C(OC)C=C3)N(CC)C2=O |
| 分子式: |
C20H24N4O4 |
| 分子量: |
384.43 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Istradefylline reduces dyskinesia resulting from long-term treatment with classical antiparkinson drugs such as levodopa. Istradefylline is an analog of caffeine. |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
| TITLE |
DOWNLOAD |
| MSDS_3576_DCAPI1080_155270-99-8 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
询盘
